Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
13,527,166
-
Share change
-
+1,657,686
-
Total reported value
-
$36,525,000
-
Put/Call ratio
-
30%
-
Price per share
-
$2.70
-
Number of holders
-
30
-
Value change
-
+$3,399,536
-
Number of buys
-
13
-
Number of sells
-
17
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) as of Q2 2017
As of 30 Jun 2017,
SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,527,166 shares.
The largest 10 holders included
Balyasny Asset Management LLC, BVF INC/IL, GREAT POINT PARTNERS LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, Boxer Capital, LLC, DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and Vivo Capital, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.